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1. Introduction 
This chapter reviews complications associated wth cataract surgery and includes discussion 
of their risk factors, clinical presentation, prevention and management strategies. For the 
sake of discussion these complications are classified into intraoperative, early postoperative 
and late postoperative complications. 
2. Anaesthesia-related complications 
Ocular anaesthesia may be complicated by both ophthalmic and systemic factors. There 
have been reports of potentially life-threatening complications, including optic nerve 
damage, globe perforation as well as brainstem anaesthesia, dysrhythmias and 
cardiovascular depression. These complications are mainly seen with sharp needle 
techniques and are rarely encountered nowadays as cataract surgery is usually performed 
under topical or sub-Tenon’s anaesthesia (1). 
2.1 Optic nerve damage 
If a sharp needle accidently penetrates the dural sheath of the optic nerve (2), the anaesthetic 
can track back to the brainstem, causing unconsciousness and severe cardiorespiratory 
collapse/arrest with a potentially lethal outcome. This complication is rare, with some 
studies suggesting an incidence of between 0.09% and 0.79% for brainstem depression (3). 
Needle trauma to the optic nerve tissue can lead to significant loss of vision (4).   
2.2 Globe perforation 
Globe perforation is a rare complication of sharp needle anaesthesia and has been reported 
with both retrobulbar and peribulbar approaches with an incidence of 0.009% to 0.13% (3). 
This complication has potential for causing severe injury to the retina and is more frequently 
encountered in highly myopic eyes and eyes that underwent scleral buckling for retinal 
detachment (2). 
Globe perforation should be suspected if hypotony is encountered after administering sharp 
needle anaesthesia. However, this could be absent if a large volume of anaesthetic has been 
injected intraocularly. Another sign is a dim red reflex and sometimes blood may be seen 
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behind the crystalline lens by the operating surgeon at the start of the operation. 
Management includes examination of the fundus to assess the extent of retinal damage and 
to apply argon laser photocoagulation or cryopexy to retinal breaks, if necessary(5). 
However, in most cases, examination of the fundus is usually difficult due to the presence of 
vitreous haemorrhage complicating the perforation. B scan ultrasonography is helpful in 
this context but vitrectomy surgery is usually indicated to remove the haemorrhage and 
deal with the retinal damage. Of note, in addition to the physical damage that could be 
caused by the needle injury to the globe, injection of the anaesthetic into the vitreous can 
also result in retinal toxicity and poor vision (6). 
2.3 Retrobulbar haemorrhage 
Retrobulbar haemorrhage is an uncommon complication of ocular anaesthesia with an 
incidence of 0.032 to 3%. The condition is more common with sharp needle techniques 
(retrobulbar and peribulbar) compared to blunt needle anaesthesia (sub-Tenon’s) (1) , and is 
more common in patients on antiplatelet medications and anticoagulants with elevated an 
International Normalised Ratio (INR) (5).  
Retrobulbar haemorrhage is an emergency condition that needs to be promptly dealt with to 
save vision. It  usually presents shortly after administration of the anaesthetic injection with 
increasing proptosis, tightness of the lids, subconjunctival  haemorrhage and elevated 
intraocular pressure (IOP) that can lead to occlusion in the central retinal artery or short post 
ciliary arteries and blindness (5).  
Initially mild intermittent compression on the globe can be helpful to stop further bleeding 
and limit progression of the haemorrhage. If this fails to resolve the condition, then pressure 
on the globe has to be relieved by performing a lateral canthotomy and cantholysis of the 
inferior crus of the lateral tarsal ligament. This is usually sufficient to decompress the orbit 
around the globe in most cases. IOP-lowering medications may be considered but these are 
usually not sufficient of their own to resolve pressure on the retinal circulation. Elective 
cataract surgery must be cancelled but may be rescheduled after at least a few weeks. While 
no immediate laboratory test is essential, patients must be re-assessed to exclude underlying 
blood dyscrasias. Subsequent cataract surgery is better performed under topical anaesthesia 
and attention should be given to normalizing the INR level if elevated and stopping 
antiplatelet medications in liaison with a physician. 
3. Surgery-related complications 
3.1 Positive vitreous pressure 
Positive vitreous pressure can occur due to poor akinesia, inadvertent pressure on the globe 
from a tight lid speculum, proptosis, retrobulbar haemorrhage, eyelid abnormalities, as well 
as high hypermetropia. In this situation the iris-lens- diaphragm is pushed forward making 
surgery difficult and increasing the risk of more serious complications including iris 
damage, posterior capsule rupture and suprachoroidal haemorrhage (5).  
Positive vitreous pressure is best dealt with by early recognition. In many cases a tight lid 
speculum is the culprit and minor adjustment of the speculum can correct the problem. Should 
this fail, attention needs to be directed to other causes including retrobulbar haemorrhage that 
usually manifests before the start of the surgery or aqueous misdirection and suprachoroidal 
haemorrhage that will present later on during the surgery. In the absence of retrobulbar 
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haemorrhage the surgeon can try to deepen the anterior chamber with a cohesive opthalmic 
viscosurgical device but should the anterior chamber remain shallow with failure of pushing 
the iris-lens diagram backwards then the surgeon has to abandon the surgery and examine the 
fundus with an indirect ophthalmoscope for the presence of suprachoroidal haemorrhage. The 
absence of suprachoroidal haemorrhage makes the diagnosis of the aqueous misdirection most 
likely and in this scenario the condition usually resolves after a few hours and surgery can be 
reconsidered later on. Management of suprachoroidal haemorrhage will be discussed 
separately in the next section. Less commonly aqueous misdirection will not resolve 
conservatively and in this case, IOP-reducing agents will need to be given and possible 
interventions up to and including vitrectomy have to be considered. 
3.2 Suprachoroidal haemorrhage  
The risk of suprachoroidal haemorrhage is much less common with phacoemulsification 
and small incision cataract surgery compared to large incision cataract surgery. Data from 
the most recent national UK-based cataract audit involving 55, 567 operated eyes with 
phacoemulsification showed an incidence of 0.07% (7). Suprachoroidal haemorrhage results 
from rupture of the posterior ciliary arteries. The exact pathogenesis is unknown; however, 
hypertension, generalised arteriosclerosis, glaucoma and high myopia are possible 
precipitating factors.  
Early recognition of suprachoroidal haemorrhage is crucial and cessation of surgery and 
immediate closure of the wound is necessary to prevent retinal extrusion (expulsive 
haemorrhage) and permanent loss of vision. This is unlikely to be seen with 
phacoemulsification surgery as the wound is usually self sealing but could be encountered 
with ECCE as wound closure is more time consuming but should be undertaken as fast as 
possible using the most readily available suture (preferably 8-0 but 6-0 sutures can be used). 
Drainage of the haemorrhage using sclerotomy guided by indirect ophthalmoscopy and / or 
B scan ultrasound can be considered. 
Visual prognosis after suprachoroidal haemorrhage can vary depending on the extent of the 
haemorrhage. Usually the haemorrhage gradually resolves over a period of time and unless 
the macula has been affected, good visual recovery is usually achieved. Primary drainage of 
the suprachoroidal haemorrhage may not be felt to be  necessary unless wound closure is 
not possible due to extreme positive pressure. Postoperatively, attention is given to control 
IOP and to treat inflammation with topical steroids and cycloplegics. Vitrectomy may be 
needed to drain a persistent large suprachoroidal haemorrhage but surgery is better to be 
deferred for 2 weeks to give time for clotted blood to liquefy.  
3.3 Descemet’s membrane detachment  
A small area of Descemet’s membrane detachment at the area of the corneal section is not 
uncommon with phacoemulsification surgery and can be left alone. A wider Descemet's 
detachment along the section would need full-thickness suturing of the cornea including 
the Descemet's membrane (8). This is difficult to perform and another option is to inject 
air or a longer acting gas intracamerally to facilitate opposition of the Descemet's 
membrane to the stroma. The condition can be avoided by careful attention to wound 
construction and size as well as by avoiding the use of blunt blades. Extremely rarely the 
corneal endothelium may become detached during wound manipluations such as wound 
hydration. 
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3.4 Posterior capsule rupture and vitreous loss 
Posterior capsule rupture is the most common major  intraoperative complication observed 
during cataract surgery. There is wide agreement among ophthalmologists that its incidence 
can be used as a measure of surgical quality and is an indicator for measuring the quality of 
surgeons in training and for cataract surgeons’ revalidation. The importance of this 
complication also stems from the fact that patients whose surgery has been complicated by 
posterior capsule rupture usually require more postoperative follow-up visits and have an 
increased risk of postoperative complications including endophthalmitis, cystoid macular 
oedema and retinal detachment. 
Several factors could predispose to posterior capsule rupture and vitreous loss during 
cataract surgery only one of which is the surgeon’s experience and skill. Posterior capsule 
rupture rates in the hands of residents have been reported to vary from 0.5% to 16%, 
varying according to experience (9). In the United Kingdom, there has been a trend for 
improvement from the mean benchmark rate of 4.4% defined in the 1997 National Survey to 
2.68% in the first Pilot National Electronic Cataract Surgery Survey and 1.92% in a current 
survey of 55 567 cases (10). The lowest  rate found in a major study has been  1.1% on certain 
supervised training lists in the UK (11). Inadequate mydriasis and a small pupil increase the 
risk of intraoperative posterior capsule rupture and visual loss because it restricts the 
surgeon’s view during surgery. Pseudoexfoliation (PXF) is another significant risk factor 
associated with vitreous loss. The risk is increased by several mechanisms including zonular 
weakness and poor pupil dilatation. Intraoperative floppy iris syndrome (IFIS) in relation to 
systemic use of tamsulosin is also one of the important causes of a poorly dilated pupil 
during cataract surgery and could make surgery very difficult due to iris billowing and 
prolapse to the wound. High myopia is also a well known risk factor for vitreous loss (12). 
Diabetes mellitus may indirectly influence the rate of posterior capsular rupture through 
different mechanisms including a rigid pupil and the possibility of the patient having a 
history of pars plana vitrectomy. 
While posterior capsule rupture can occur at any stage of cataract surgery, it commonly 
occurs in the hands of most surgeons towards the end of the surgery at the time of cortex 
removal or otherwise while removing the last quadrant of the nucleus mainly because the 
posterior capsule is more exposed at these stages of the operation.  Another cause of 
posterior capsular tear is an extension of an anterior capsule tear that wraps around the 
equator - this could occur at the early stage of capsulorrhexis though extension can also 
occur later on during the surgery. In a large retrospective study of 2646 cases that were 
operated on by a single experienced surgeon, a tear in the anterior capsule rim was observed 
in 21 eyes (0.79 %) and extension of the tear into the posterior capsule occurred in almost 
half the eyes with an anterior capsule tear (13). 
Appropriate risk assessment can significantly decrease the risk of intraoperative posterior 
capsule rupture and vitreous loss. Difficult cases with small pupil, PXF or anticipated IFIS 
should only be undertaken by senior surgeons or trainees that are at the end of their training 
programme. Risks inherent to small pupil size or iris billowing could be dealt with 
intraoperatively with the use of a super-cohesive ophthalmic viscosurgical device (OVD) such 
as Healon 5 or mechanical measures to dilate and restrain the iris movement such as iris hooks 
or  pupil expansion rings. Posterior capsule rupture can also be avoided by taking extra 
caution during emulsifying the last nucleus quadrant to protect the posterior capsule through 
maintaining the anterior chamber depth. Bimanual irrigation aspiration may be safer than 
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coaxial irrigation aspiration as the aspiration port is always directed up and is therefore 
unlikely to snag the capsule. For anterior capsule tears, the surgeon should be aware of their 
risk of extension into the posterior capsule and redirection of the tear centrally to the desired 
circumferential path should be attempted unless the tear has extended into the zonules. This 
can be achieved with the capsulorrhexis tear-out rescue technique described by Little and 
associates (14). In this technique the authors recommend first filling the anterior chamber with 
a cohesive OVD and then folding the progressing anterior capsule flap back on the intact 
portion of the anterior capsule by forceps and then pulling it centrally to redirect the tear with 
the force applied in the plane of anterior capsule (14). 
If posterior capsule rupture is suspected then the surgeon should stop aspiration and 
phacoemulsification but maintain irrigation and then inject a cohesive viscoelastic through 
the side port before withdrawing the handpiece from the eye. Maintaining the anterior 
chamber depth can prevent extension of the posterior capsule tear and avoid disruption of 
the anterior vitreous face and vitreous prolapse. Further management depends on the stage 
at which capsule rupture occurs and whether there is vitreous prolapse into the anterior 
chamber (‘vitreous loss’). If the anterior hyaloid face is intact, removal of residual cortex can 
be performed using dry aspiration while the anterior chamber is maintained with a cohesive 
OVD. Another technique is bimanual irrigation aspiration with the irrigation and suction 
kept to a minimum and the irrigation flow directed away from the tear so as not to disrupt 
the anterior vitreous face. At all stages of the surgery, the anterior chamber depth should 
always be maintained. 
Vitreous prolapse if it occurs has to be dealt with using anterior vitrectomy. Triamcinolone 
is increasingly used by surgeons to visualise vitreous. Bimanual vitrectomy through two 
side ports is the preferred technique as the anterior chamber depth is maintained with this 
approach limiting the amount of prolapsing vitreous. Trimacinolone serves as a good tool to 
visualize vitreous fibrils when injected in the anterior chamber and ensures complete 
anterior vitrectomy.    
If there is a small central posterior capsule tear, an experienced surgeon can still implant the 
lens in the bag preferably after converting it to a posterior capsulorrhexis. In this case, a one-
piece lens is much easier to implant. Should this not be feasible then the surgeon can place 
the intraocular lens in the ciliary sulcus provided that there is sufficient capsular support. 
Capturing the optic through an intact capsulorrhexis can also be performed to help better 
centralisation of the lens optic (‘optic capture’). 
Any intraocular lens (IOL) placed in the ciliary sulcus should have sufficient posterior iris 
clearance and secure fixation. Therefore the choice is between a 3-piece foldable posterior 
chamber intraocular lens (PCIOL) and a polymethymethacrylate (PMMA) IOL. A 3-piece 
foldable PCIOL has the advantage of thin, posteriorly angulated C-shaped haptics that do 
not contact the iris. Ideally, the anterior optic surface should be smooth and have rounded 
edges to minimize iris chafing and the overall IOL length should be at least 13.5 mm. It is 
important to reduce the risk of iris chafing that the IOL is inserted with the correct face 
forwards. Because of the risk of retinal detachment with posterior capsule rupture and 
vitreous loss, silicone intraocular lenses are better avoided as they may compromise the 
view should vitrectomy surgery become required. With optic capture, the same IOL power 
calculated for capsular bag fixation can generally be used. However, should optic capture 
not be feasible with sulcul IOL, the lens optic will have a more anterior location and the lens 
power should be reduced by 0.5 to 1.0 D (15). A large diameter (>13.5 mm) PMMA PC IOL 
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is another option but the incision will need to be enlarged to at least 6.5 mm which is not 
desirable (15). Single piece acrylic lenses are not recommended for ciliary sulcus placement. 
The haptics are thick and not posteriorly angulated and will therefore contact the posterior 
surface of the iris when implanted in the sulcus. Furthermore, the overall loop-to-loop 
dimension of these lenses is only 13.0 mm or less which is short for many eyes. The square 
edge optic design increases iris chaffing (15).   
In eyes with insufficient capsule support, the surgeon has the choice between iris- or scleral-
sutured PC IOLs and open loop AC IOLs. In our experience placing an AC IOL is a much 
easier technique than suturing a PC IOL during the primary surgery (Figure 1).The 
American Academy of Ophthalmology Technology Assessment study reviewed more than 
40 papers that addressed the outcomes of IOLs implanted without adequate capsule support 
and carried evidence rating of level III or higher. The study was unable to find a significant 
difference in the safety or efficacy of these 3 methods and therefore use of any of these 
modalities is appropriate and is left to the discretion of the surgeon (16). 
 
 
Fig. 1. Anterior chamber intraocular lens in a case of cataract surgery complicated by 
posterior capsule rupture. Note the presence of a peripheral  iridectomy. 
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3.5 Zonular dialysis 
A preoperative zonular dialysis may be the result of pre-existing conditions as traumatic 
cataract or in association with specific disorders as Marfan Syndrome and Weill-Marchesani 
Syndrome. Pseudoexfoliation and high myopia are other well recognized causes for zonular 
weakness and dialysis preoperatively. Signs that could alert the surgeon to the presence of 
zonular dialysis include phacodonesis, iridodonesis, presence of vitreous in the anterior 
chamber, or a visible zonular defect. Moreover, the nucleus may appear decentralised (off-
centre) with a gap between the iris border and the lens. 
Intraoperative zonular dialysis may result from vigorous manoeuvres that traumatise the 
zonules in one region. These include a traumatic capsulorrhexis, excessive manipulation of 
the nucleus, or inadvertent aspiration of the capsular bag or anterior capsule. Prompt 
recognition and early management can decrease the risk of intraoperative vitreous prolapse 
and postoperative lens decentration or posterior dislocation. Small areas of zonular dialysis 
(45 degrees or less) recognized at the time of surgery can be dealt with only by maintaining 
the anterior chamber depth at the time of surgery to limit further progression and prevent 
vitreous prolapse. A larger defect usually necessitates the use of a capsule tension ring 
(CTR) to preserve the integrity of the capsular bag and provide the necessary capsular 
support. It works by reducing asymmetric capsular forces, stabilizing the vitreous base. 
Moreover, it facilitates phacoemulsification and IOL implantation and decreases 
postoperative IOL decentration and capsular phimosis.  Modified CTR designs are also 
available and can even be sutured to the sclera to provide additional support to the capsular 
bag in eyes with very loose zonules.  
4. Early postoperative complications 
4.1 Shallow anterior chamber (AC) 
A shallow anterior chamber after cataract surgery may be associated with low or high IOP. 
Wound leak is the most common cause of shallow AC with low IOP and therefore, the 
initial work up aims to check for a wound integrity and perform a Seidel test. Other causes 
include choroidal effusion or severe uveitis with decreased aqueous formation. 
Management is directed towards treating the underlying problem in case of a wound leak 
and uveitis while choroidal effusion is usually self limiting. 
Shallow anterior chamber with elevated IOP could be due to pupil block glaucoma, 
suprachoroidal haemorrhage or malignant glaucoma. Pupil block is an uncommonly 
encountered complication after cataract surgery where the aqueous humour accumulates 
under the iris causing the peripheral iris to balloon forward resulting in angle closure 
glaucoma. The pupillary aperture may be obstructed by complete adhesions between 
pupillary border of the iris (seclusio pupillae) and lens implant in eyes with severe 
postoperative uveitis. Other causes include pupil block caused by the anterior hyaloid or 
lens implant and for this reason it is essential to perform a peripheral iridectomy when 
implanting an anterior chamber IOL. Retained viscoelastic accumulating behind the lens 
implant can increase the pressure inside the capsular bag and induce pupil block i.e. 
capsular distension syndrome. These eyes will have an unexpected degree of myopia which 
is an important clue to the diagnosis.  
Malignant glaucoma is a rare complication after cataract surgery. A blockage of the normal 
aqueous exchange between the posterior chamber and the anterior vitreous is believed to 
cause malignant glaucoma. Posterior misdirection of aqueous humor into the vitreous cavity 
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occurs producing a continuous expansion of the vitreous cavity with increased posterior 
segment pressure. This accumulation of aqueous in the vitreous cavity causes anterior 
displacement of the lens-iris diaphragm. The resulting shallow or flat AC is believed to 
exacerbate the condition because of the decreased access of aqueous to the trabecular 
meshwork. After excluding the presence of pupillary block initial management should be 
conservative with topical mydriatics and IOP lowering agents including systemic carbonic 
anhydrase inhibitors and osmotic agents as mannitol. Nd: YAG laser can be performed to 
disrupt the anterior vitreous face but surgical management in the form of vitrectomy should 
be performed if conservative treatment and laser fail to resolve the condition. Management 
of suprachoroidal haemorrhage has been discussed earlier in this chapter.  
4.2 Iris prolapse 
Iris prolapse can result from inadequate wound closure, accidental postoperative trauma, or 
raised intraocular pressure. Phacoemulsification wounds are usually self sealing but 
surgeons should confirm the absence of wound leak at the conclusion of the surgery and not 
hesitate to suture the wound if needed.   
If iris prolapse is of less than 48 hours duration, the iris can be repositioned and the wound 
is closed. In cases where iris prolapsed has been present for a longer time, iris excision is 
usually needed to decrease risk of intraocular infection.  
4.3 Postoperative uveitis 
Mild anterior uveitis is not uncommon after uncomplicated phacoemulsification surgery 
and usually responds well to routine postoperative corticosteroid drops. Concerns are 
raised when a patient presents in the early postoperative period with more than a mild 
postoperative inflammation as this could be endophthalmitis even in the absence of pain 
and poor vision. As long as the vitreous remains quiet and the anterior chamber 
inflammation is not worsening, a sensible strategy is to increase the frequency of topical 
steroids and review the patient after several hours and then the next morning. However, 
diagnosis of endophthalmitis should be considered if symptoms worsen within 6 to 12 
hours and emergency treatment should be commenced without delay. 
4.4 Infectious endophthalmitis 
Infectious endophthalmitis is the most serious postoperative complication of cataract 
surgery. Fortunately the incidence is very low and ranges from 1- 3 in 1000 or even less (17). 
Postoperative endophthalmitis can present as early as the first postoperative day and up to 
two weeks after surgery. However, most commonly it presents after 3-4 days. Presenting 
symptoms can include decreased vision and pain although pain is not a constant feature. 
The anterior chamber inflammation seen is usually significantly greater than that expected 
after surgery (Figure 2), with extension of inflammation to the vitreous cavity. Other classic 
signs of endophthalmitis are lid swelling, conjunctival injection, corneal oedema, vitreous 
abscess and retinitis but these could all be absent in early cases and are not essential for 
making the diagnosis. The Endophthalmitis Vitrectomy Study (EVS) found that at 
presentation, 86% of cases of acute postoperative endophthalmitis had hypopyon which can 
cause an increase in IOP. The majority of these patients complained of progressive pain and 
reduction in vision and 86% had acuity of 5/200 on initial presentation and 26% had light 
perception only (18). 
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Fig. 2. Marked anterior chamber inflammation and hypopyon in a patient  with infective 
endophthalmitis 
The majority of cases of postoperative endophthalmitis result from intraocular microbial 
contamination from the patient's skin, preocular tear film or ocular adnexa. Posterior 
capsule rupture is a well known risk factor and it is therefore recommended that the cataract 
wound is sutured after complicated cases (19). Other risk factors include patient age, 
intraoperative surgical complications, and poor wound construction. In a case-control study 
of 10 patients, endophthalmitis after secondary IOL was associated with diabetes, trans-
scleral suture fixation of posterior chamber IOLs, polypropylene haptics, and intraocular re-
entry through the old wound (20). 
 The most common pathogens are gram-positive cocci, Streptococcus epidermidis and 
Staphylococcus (Staph) aureus.  Staph aureus endophthalmitis often leads to a more virulent 
and destructive pattern of visual loss in comparison to that of Staph epidermidis. Gram-
negative pathogens can also cause severe bacterial endophthalmitis with Pseudomonas 
aeruginosa being the most common casual agent. The normal flora colonising the eyelids and 
the lashes are the main source of bacteria in endophthalmitis post cataract surgery but other 
sources of infection include contaminated infusion solutions or instruments and aerosols in 
the operating theatre (21). 
Several antibacterial protocols exist to prevent the occurrence of postoperative 
endophthalmitis, with topical, intracameral and subconjunctival delivery being the most 
common approaches. Worldwide, there seems to be significant variation in the methods of 
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delivery of prophylactic antibacterial regimens; for example, topical fluoroquinolones are 
commonly used in the United States, while intracameral cephalosporins are employed 
broadly in Europe. The optimal antibacterial strategy for the prevention of endophthalmitis 
should be the administration  of safe, inexpensive antibiotics with a broad spectrum of 
activity and which also do not require patient compliance for effectiveness (22). In addition, 
detection and treatment of blepharitis preoperatively as well as preoperative administration 
of povidine iodine in the conjunctival sac reduces the incidence of postoperative 
endophthalmitis and are widely employed measures.  
Intravitreal injection of antibiotics is the mainstay of treatment for postoperative 
endophthalmitis and needs to be commenced without delay once the diagnosis is made. 
Empirical antibiotics to cover gram positive and gram negative organisms are usually used 
after performing a vitreous tap for culture and sensitivity. With the rising incidence of 
resistant beta-lactam bacteria, intravitreal injection of vancomycin is the treatment of choice 
to cover gram-positive organisms. Vancomycin is a bactericidal agent that works by 
preventing the polymerisation of peptidoglycan in the cell wall and thus causes loss of cell 
wall integrity with cell lysis. The drug is used at a dose of 1.0-2.0mg/0.1ml and has been 
reported to have 100% efficacy against gram-positive bacteria but has no efficacy against 
gram-negative organisms (21). Cover for gram-negative organisms requires an agent with 
activity against Pseudomonas aeroginosa. Ceftazidime at a dose of 2.00-2.25 mg/0.1 ml or 
amikacin at a dose of 0.4 mg/0.1 ml may be used and have similar success rates close to 
90%. Aminoglycosides are also synergistic with vancomycin against gram-positive 
organisms. However, both gentamicin and amikacin carry a small risk of retinal toxicity and 
macular infarction when injected intraocularly, but the risk is small and amikacin in 
particular is widely used (21). The toxic effect can even occur with smaller doses. A localised 
increase in the concentration may play a part in causing the toxicity. Also, ceftazidime 2.0 
mg may be used instead of aminoglycosides in the treatment as well as prophylaxis of gram 
negative infection (23). Some centres also administer systemic antibiotics alongside 
intravitreal agents. 
Pars plana vitrectomy (PPV) may be necessary for the management of acute 
endophthalmitis; however the need for vitrectomy in all cases of postoperative 
endophthalmitis remains questionable. While vitrectomy is expected to decrease the 
microbial load and increase intraocular diffusion of antibiotics, it carries the potential risk of 
causing retinal detachment and intraocular haemorrhage in cases of intraocular infection 
(24). As per the EVS recommendations, patients with only light perception or worse benefit 
from PPV with a significantly better outcome. However, different centres have different 
protocols and some centres treat all cases initially with intravitreal antibiotics irrespective of 
the level of vision and consider vitrectomy for cases that do not respond (24). 
Visual prognosis is strongly associated with the type of microorganisms that are cultured. 
Gram positive coagulase negative cocci are associated with the best prognosis whilst 
Streptococci as well as enterococci seem to be associated with the worst visual outcome. 
Presenting visual acuity is a more powerful predictor of visual prognosis than the 
microbiological factors. Bacterial growths from vitrectomy cassette specimens have the same 
prognostic value as specimens taken from other intraocular sources (25). 
The chronic form of postoperative endophthalmitis is more insidious and usually manifests 
after several weeks or even months after the surgery (figure 2).The ratio of acute to chronic 
cases ranges between 5:1 to 2:1 (17). The organisms responsible tend to be less virulent 
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bacteria or fungi. The inflammation may initially be controlled by postoperative topical 
steroids but rebound inflammation is common as the steroids are tapered. These cases may 
be treated with intravitreal antibiotics including vancomycin however in resistant cases 
treatment directed at surgical removal of the sequestered organisms through removing the 
intraocular lens and total removal of the capsular bag results in a lower recurrence rate (26). 
4.5 Toxic anterior segment syndrome (TASS) 
Over the last three decades several authors have reported a non-infectious condition 
mimicking endophthalmitis following cataract surgery (26). Initially it was termed “sterile 
postoperative endophthalmitis” however this was a misnomer, as unlike endophthalmitis, 
the inflammation is limited only to the anterior segment and does not extend to the vitreous 
cavity. It was later renamed ‘toxic anterior segment syndrome' (TASS) (27). 
TASS generally presents with severe inflammation that is restricted to the anterior chamber 
as mentioned before, often resulting in hypopyon. In severe cases of TASS, fibrin may be 
present in the anterior chamber, on the iris or on the IOL surface. Inflammatory membranes 
can develop, which result in iris damage and an irregular pupil with impaired pupil 
function. During the early stages of the condition the IOP is low but the inflammatory 
membrane can creep over the trabecular meshwork. These changes can result in ocular 
hypertension or the development of secondary glaucoma and the rise in IOP can be severe. 
A number of possible causes have been identified as triggering factors. They include 
preservatives in drugs or the irrigating solution injected into the anterior chamber during 
surgery, traces of chemicals used in the sterilization process remaining on the surgical 
instruments or contamination of these instruments with bacterial endotoxins during 
sterilisation (28). Because TASS is a toxic insult, it almost always presents as an atypical and 
unusual form of inflammation one day after surgery.  
Differentiation between TASS and infective endophthalmitis is very important but can 
sometimes be difficult. First, TASS is only an anterior segment inflammation whereas 
endophthalmitis involves both anterior and posterior segments with extension of the 
inflammation into the vitreous (29). Second, TASS occurs within the first 24 hours in the 
postoperative period, however, endophthalmitis is not uncommonly delayed for 4 -7 days 
and very rarely presents on the first day. Third, patients with infective endophthalmitis are 
usually more symptomatic than TASS patients who may only complain of mild discomfort. 
Fourth, limbus-to-limbus corneal oedema is an important differentiating finding strongly 
suggestive of TASS. If this sign is present on the first postoperative day, a diagnosis of TASS 
should be strongly considered. Nonetheless, endophthalmitis should never be eliminated as 
a diagnosis until the therapeutic response is measured and the inflammation remains 
confined to the anterior segment. Fifth, in an eye with TASS, a fixed dilated pupil, often with 
mottled or diffuse areas of iris atrophy, is not uncommon. However this is unlikely to be 
encountered in cases of infective endophthalmitis. Finally, a severe rise of IOP early in the 
postoperative period is an uncommon finding with endophthalmitis and is more suggestive 
of TASS (30).  
Topical steroids comprise the first line of treatment of TASS. Patients should receive hourly 
topical steroids and remain in the clinic to be monitored during the day. Steroids can 
suppress inflammation from endophthalmitis for a short period of time and accordingly the 
diagnosis of endophthalmitis must be reconsidered if symptoms and signs are getting worse 
with the use of steroids. For mild or moderate cases of TASS most cases will respond well to 
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topical treatment and recover with time. Severe cases may require the use of oral steroids 
and visual outcome can be poor due to non resolving corneal oedema or refractory 
glaucoma.  
4.6 Retained Lens Material 
Inadequate aspiration of the cortex, especially of the subincisional cortex if the surgeon is 
using a coaxial irrigation aspiration, is the commonest cause of retained lens material after 
cataract surgery. This is usually in the form of soft lens matter.  
Retained lens material excites an inflammatory reaction in the eye. In cases with minimal 
cortical matter, the anterior segment inflammation can be controlled medically with topical 
steroids and cycloplegics until the lens material is absorbed. In cases with significant cortical 
residue, surgical removal is essential as they can cause significant inflammation with raised 
IOP and can also move centrally to obstruct the visual axis. There should be a low threshold 
for intervening quickly with surgery to remove the retained lens matter if intraocular 
pressure and /or intraocular inflammation is proving difficult to control. 
5. Late postoperative complications 
5.1 Change in refraction / astigmatism 
Corneal topography has been used to evaluate postoperative astigmatism. Topographic 
analysis has shown a mean flattening of 0.4 to 1.0 dioptre in the temporal region after a 
sutureless 3 mm temporal corneal incision with no significant vertical steeping or nasal 
flattening in the majority of patients (31). 
In patients with a pre-existing small degree of corneal astigmatism (up to 0.75D), this can be 
tailored for a favourable outcome by manipulating the incision parameters (size, location 
and shape). On-axis incisions are the most widely used of these approaches.  However cases 
with more significant amount of astigmatism are unlikely to benefit from incision site 
modification but could benefit from combined cataract surgery and limbal relaxing incisions 
or toric intraocular lens implantation.  
5.2 Refractive surprises after cataract surgery 
Refractive surprises following cataract surgery can be due to inaccurate biometry, insertion 
of the wrong IOL (either due to manufacturer-associated or surgeon-associated errors) or 
previous corneal refractive procedures. The best markers of the quality of a biometry service 
are the percentage of eyes achieving a postoperative spherical equivalent refraction within 
0.5 and 1.0D of the target refraction and the total range of refractive error (32). The Royal 
College of Ophthalmologists (RCOphth) 2004 cataract surgery guidelines state that both 
optical (partial coherence interferometry (PCI)) and acoustic (ultrasound) methods of axial 
length measurement can be routinely used (33), although it has been shown that PCI 
reduces the prediction error of postoperative refractive outcome. The RCOphth guidelines 
state that each ophthalmology department, if not each surgeon, should personalise the A 
constant on the basis of continuous audit of the comparison of the predicted and actual 
spherical equivalent of the postoperative subjective refraction (34). 
IOL power calculations in cataract patients who have formerly undergone keratorefractive 
surgery are often less precise than they are for patients who have not had refractive 
procedures. This is mainly due to errors in determination of corneal refractive powers and 
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using wrong keratometry values and is more common in patients who have undergone 
myopic keratorefractive surgery. As their corneal refractive power may be overestimated, 
this may lead to a hyperopic postoperative refractive outcome. Several options are available 
for subsequent correction of refractive surprises, including prescription of spectacles or 
contact lenses, IOL exchange, keratorefractive surgery, or implantation of a supplementary 
IOL (i.e., polypseudophakia) (35). 
Spectacles may not be ideal for some young self-conscious patients. Likewise contact lenses 
may not be suitable for older patients. Keratorefractive procedures may not be the best 
solution due to the inherent risks associated with further corneal surgery. IOL exchange and 
supplementary IOLs, implanted in the ciliary sulcus anterior to the primary implant, can be 
an option, especially when capsular changes have firmly fixed the primary implant within 
the capsular bag making IOL exchange surgically challenging with very significant risks of  
posterior capsule and zonular rupture (35). 
5.3 Posterior capsule opacification (PCO) 
A thickened posterior capsule is the most common postoperative cause of decreased vision 
following cataract surgery with a prevalence of over 40% in many studies within five years 
of surgery.  It is a multi-factorial problem related to patient factors such as age, surgical 
factors and also factors in the IOL design.  
PCO is caused by residual lens epithelial cells, which are left behind after cataract surgery. 
These residual lens epithelial cells have been shown to produce interleukins (36-38), 
fibroblast growth factor and transforming growth factor beta in inoculation media. 
Cytokines may also play a role in the proliferation and development of lens epithelial cells; 
therefore inhibition of cytokines may lead to prevention of PCO (39). There is also some 
evidence that the proliferation of lens epithelial cells (Elschnig’s pearls) may be linked to the 
severity and duration of intraoperative or postoperative inflammation.  
The IOL implant itself creates a physical barrier between the anterior and posterior lens 
capsule and IOL designs with square edged optics provide a more effective barrier than 
round edges thus minimising the risk of PCO. This is usually more effective when the 
anterior capsulorrhexis is continuous, well centred and overlaps the implant edge by 1-2 
mm.  Intraocular lens designs have also been improved to reduce trauma and thus decrease 
the likelihood of epithelial cell proliferation. Together with appropriate aspiration of cortical 
lens matter and improved surgical experience, these techniques have reduced the 
prevalence of PCO (40).  
PCO is treated with Neodymium:Yttrium Aluminium Garnet (Nd:YAG) laser capsulotomy, 
preferably six months after surgery after stabilisation of the blood-ocular barrier (Figure 3). 
Nd:YAG laser capsulotomy should begin with minimal power and an adequate opening 
should be created, at least encompassing the pupillary area in the undilated position. For 
patients who require regular fundus examination such as patients with diabetic retinopathy 
a wider capsulotomy opening is more preferable. 
Although Nd: YAG laser capsulotomy is a straightforward procedure, it is not entirely 
without risk.  Iatrogenic complications of Nd:YAG laser capsulotomy include corneal 
endothelial loss, increase in IOP, uveitis, and retinal detachment. Accidental lens pitting can 
occur in up to 30% of patients and laser burns on silicone IOLs can resemble pigment 
deposition (41).  
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Fig. 3. Nd: YAG posterior capsulotomy laser for posterior capsule  opacification 
6. Cystoid macular oedema (CMO) 
Advances in cataract surgery techniques and increasing awareness of the importance of 
minimizing vitreous loss have resulted in a marked reduction in the incidence of cystoid 
macular oedema (CMO) compared with the era of intracapsular cataract surgery (42,43). 
Cystoid macular oedema is now considered an infrequent complication and the literature 
suggests that the incidence of pseudophakic CMO following uncomplicated 
phacoemulsification of the lens and implantation of an in-the-bag intraocular lens is 0.6–6% 
(43). The incidence of CMO is higher if the surgery is complicated (e.g., posterior capsule 
rupture with or without vitreous loss, iris damage and vitreous incarceration through the 
wound) (44). It is also more common in diabetic eyes and in patients with pre-existing uveitis 
(45,46). 
CMO following cataract surgery results from the maldistribution of intravascular fluid 
within the macula. Leakage of intravascular contents from the dilated perifoveal capillaries 
initially causes thickening of the macula, which may progress to cystoid expansions within 
the outer plexiform (Henle’s) layer and inner nuclear layer of the retina (47). Most 
investigators agree that inflammation is the major aetiologic factor with prostaglandin 
release being implicated as the possible mediator of inflammation (48).  
Pseudophakic CMO is characterized by poor postoperative visual acuity. CMO has a peak 
incidence of 4-6 weeks following cataract surgery (49) but can occur earlier in complicated 
cases. Diagnosis is made after slit lamp biomicroscopy but subtle cases can be diagnosed 
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with optical coherence tomography examination (OCT) (Figure 4). Fundus fluorescein 
angiography could also be helpful in diagnosis of CMO and usually shows perifoveal 
petaloid staining pattern and late leakage of the optic disc but is not needed in all cases and 
has been superceded by OCT.  
 
 
Fig. 4. Optical coherence tomography photographs of chronic cystoid  macular oedema 
before (a) and after (b) treatment with intravitreal  triamcinolone. 
Most CMO cases (>80%) will resolve spontaneously within weeks to months. The presence of 
chronic CMO however occurs in a small proportion of patients (1%) leading to chronic or 
permanent vision loss and hence the argument for early diagnosis and treatment of CMO. 
Several studies have considered the effect of pharmacologic and surgical treatments for 
pseudophakic CMO.  Most clinicians use a combination of topical corticosteroids and non 
steroidal anti-inflammatory drugs (NSAIDs) as a first-line treatment in most instances (50). 
Corticosteroids inhibit several parts of inflammation including prostaglandin synthesis by 
inhibiting the enzyme phospholipase A2, while NSAIDs interrupt prostaglandin synthesis by 
inhibiting the enzyme cyclo-oxygenase. A course of 6 weeks treatment is usually tried before a 
second line treatment is considered. For cases that do not respond, treatment options include 
periocular or intravitreal steroids and oral acetazolamide. Periocular steroids (sub-Tenon or 
peribulbar) have the advantageous of being able to reach the posterior segment of the eye in a 
higher concentration compared to topical application and have less ocular side effects compared 
to the intravitreal route. Side effects include raised intraocular pressure, cataract, orbital fat 
prolapse and ptosis but these are less likely to occur after a single injection. Intravitreal 
triamcinolone injection is an effective treatment option for resistant postoperative CMO, 
although there are no randomized prospective trials to date.  Intravitreal triamcinolone results 
in a rapid improvement in visual acuity that may be sustained for more than 6 months (51-52). 
However it is associated with significant ocular morbidity including a high risk of cataract, 
ocular hypertension and a small risk of infectious or sterile endophthalmitis (Figure 5). 
Carbonic anhydrase inhibitors (CAIs), such as acetazolamide, have been used in cases 
resistant to standard topical treatment with some success (53, 54).They enhance the 
pumping action of retinal pigment epithelial cells, facilitating the transport of fluid across 
the retina.  However, there are no controlled studies that demonstrated a positive effect of 
acetazolamide on pseudophakic macular oedema. 
Bevacizumab (Avastin) is a monoclonal antibody able to inactivate the effects of vascular 
endothelial growth factors (VEGF). The role of VEGF in pseudophakic CMO is not clear, yet 
several authors have reported resolution of CMO after administration of bevacizumab (55) 
retrospectively. This class of drugs could be of benefit in patients with chronic CMO that 
have exhibited a steroid hypertensive response to topical or periocular steroids. However, a 
report by Spitzer et al did not find any beneficial effects with this treatment (56).  
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When vitreous is incarcerated in the corneal wound following complicated cataract surgery, 
Nd:YAG laser lysis of vitreous strands has been shown to have a positive effect on restoring 
the retinal vascular stability and reduction of macular oedema (57). Finally, pars plana 
vitrectomy (PPV) could be employed in the management of chronic postoperative CMO 
(58). This helps to remove vitreous strands tracking to the surgical wound after complicated 
ocular surgery as well as peeling of epiretinal membranes from the surface of the macula 
when associated with CMO. It also works by removal of inflammatory mediators from the 
vitreous or retained nuclear lens fragments and possibly by increasing oxygen diffusion to 
the macula. 
 
 
 
 
Fig. 5. Sterile endophthalmitis with a pseudohypopyon due to deposition of triamcinolone  
crystals in the anterior segment after intravitreal triamcinolone treatment. 
There is debate whether routine prophylactic treatment of CMO is needed as the cost:benefit 
ratio of treatment and long term visual benefit are not clear. Unless a patient presented with 
risk factors for developing CMO—diabetes, previous vein occlusions, uveitis or epiretinal 
membrane, prophylactic intervention prior to cataract is usually not employed by most 
clinicians. When indicated, topical NSAIDs are the most widely used class of drugs in the 
prophylaxis of pseudophakic CMO and several studies have reported that they are effective 
in this context (59). 
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6.1 Posterior vitreous detachment and rhegmatogenous retinal detachment  
Posterior vitreous detachment (PVD) is considered to be common following cataract surgery 
and can occur at any time. A published study found a prevalence of PVD in 50.8% of eyes 
that had undergone cataract surgery compared to 20.8% in the fellow unoperated eye (60). 
The removal of the crystalline lens and its replacement with a thinner IOL implant leaves 
more space inside the globe for the vitreous to move forward which may induce a 
detachment from the posterior pole. The study also found that eyes with an axial length of 
more than 25mm were at increased risk of developing PVD (60). 
Rhegmatogenous retinal detachment (RRD) is rare but is a serious potential complication of 
cataract surgery. The prevalence is much lower with phacoemulsification and small incision 
surgery than that found after intra-capsular cataract extraction (ICCE). It is this increased 
incidence of PVD after cataract surgery that is the main precipitating factor in the 
development of retinal breaks and subsequent pseudophakic RRD. 75% of retinal 
detachments occur in the first year while the other quarter may develop within 4 years of 
surgery (61). The risk of RRD appears to be increased in male patients, myopes and very 
significantly in those patients who have vitreous loss at the time of cataract surgery. It was 
also found that scleral-sutured posterior chamber intraocular lenses (PCIOLs) may be 
associated with a high risk of RD due to pre-existing conditions (myopia, aphakia and 
vitreous loss) and vitreous disturbances as well as pars plana entry sites during IOL fixation. 
In addition, retinal breaks may result from traumatic incarceration of the IOL and pre-
retinal manipulation of dislocated IOLs (62). Nd:YAG laser posterior capsulotomy may 
increase the risk of retinal detachment after cataract surgery. The hazard ratio of RD after 
Nd:YAG laser posterior capsulotomy was 4.9, however, this risk is changed by a factor of 1.3 
with an increase of axial length of 1 mm and by a factor of 0.94 for each added year of the 
patient’s age (63). 
Pseudophakic retinal detachment can be treated with a number of different approaches 
including pneumatic retinopexy, scleral buckling and primary pars plana vitrectomy. While 
choice of surgery  remains a matter of personal choice for the surgeon, there is growing 
popularity in use of pars plana  vitrectomy for treatment of retinal detachment particularly 
because retinal tears in pseudophakic eyes could be multiple and thus difficult to treat 
successfully with pneumatic retinopexy or a localized buckle.  One recent prospective 
randomized trial that compared primary vitrectomy and scleral buckling in 
rhegmatogenous retinal detachment showed superiority of the former over the latter in 
pseudophakic eyes (64). 
6.2 Lens dislocation 
This is a rare complication with the patient complaining of blurred vision, glare and 
possibly monocular diplopia. The visual symptoms can be potentially disabling for the 
patient and requires repositioning of the lens, or IOL exchange. The IOL implant can be 
displaced by asymmetrical thickening or fibrosis of the lens capsule particularly in cases 
complicated by zonular dehiscence or patients with pre-existing weakness of the zonules as 
in pseudoexfoliation syndrome. Lens dislocation can also result from ocular trauma or 
previous pars plana vitrectomy. 
A major problem associated with posteriorly dislocated IOL is retinal damage during the 
intraocular manipulations. Removal of a posteriorly located IOL through the corneal wound 
is hazardous and should not be attempted. Pars plana vitrectomy surgery is needed for 
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retrieval of the lens from the vitreous followed by IOL exchange or repositioning in the 
ciliary sulcus with or without suturing to the sclera (65). However, some patients may be 
treated conservatively and their aphakia corrected with a contact lens or secondary lens 
implant. 
6.3 Capsular block syndrome 
Also known as capsular bag distension, this occurs after cataract removal and placement of 
a posterior chamber IOL. Typically the patient reports blurring of vision postoperatively, 
which is usually found to be due to an induced myopic shift, although a hyperopic shift or 
no refractive change have also been reported(66-68). 
The pathogenesis of this condition may be due to a fibrotic reaction with a larger lens optic 
in the capsular bag allowing enhanced adhesion between the lens and the capsule resulting 
in sealing of the capsulorrhexis(2). It is postulated that this syndrome may result from 
osmotic movement of fluid due to various types of collagen and substances produced by the 
proliferating lens epithelial cells and is associated with lens capsule thickening (69, 70). 
Nd:YAG posterior capsulotomy laser is usually performed to release the fluid into the 
vitreous cavity and in most cases this is sufficient to improve the vision. Retained 
viscoelastic behind the lens can also cause this condition and may have to be removed 
surgically. 
6.4 Ptosis and diplopia 
This is an unusual complication of cataract surgery and usually occurs several months later. 
It is important to take a thorough ocular history, as it is possible that the ptosis may have 
been present prior to cataract surgery but went unnoticed. 
This form of ptosis is often transient and does not require intervention, although 
persistent ptosis may require surgical intervention. Causes of persistent ptosis usually 
involve damage to the levator muscle due to the toxic effects of anaesthesia, prolonged 
oedema, and trauma from direct injection into the muscle, or from the lid speculum 
during cataract surgery.  
Persistent diplopia is an uncommon complication after cataract surgery. Some cases are due 
to vertical or less commonly horizontal muscle imbalance which is thought to be due to 
direct surgical trauma or due to an anaesthetic myotoxic effect (71). Patients with pre-
operative diplopia should also be counselled about this risk as the deviation may be 
unstable in a quite large proportion of these patients and some cases may need surgical 
treatment to correct their diplopia (72). Another cause of postoperative diplopia is 
aniseikonia due to surgically induced anisometropia.  
6.5 Corneal oedema and pseudophakic bullous keratopathy (PBK)  
Postoperative corneal oedema is not a rare complication of phacoemulsification. Epithelial 
oedema (that is not associated with stromal oedema) is usually due to increased IOP and is 
reversible when the cause is treated.  Presence of corneal stromal oedema postoperatively is 
a sign of endothelial damage. This may result from pre-existing endothelial pathology as in 
Fuch’s Endothelial Dystrophy or intraoperative endothelial trauma particularly after 
phacoemulsification of dense nuclei and in complicated cases with posterior capsular 
rupture and vitreous loss. Postoperative uveitis can also lead to endothelial cell loss and 
corneal oedema as in TASS.  
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Postoperatively, corneal stromal oedema can be localized or diffuse and is usually 
associated with underlying Descemet's membrane folds, hence the name striate 
keratopathy. Clinically, this could also be associated with epithelial oedema and in severe 
cases epithelial bullae may be seen. Vision is usually significantly affected in patients with 
striate keratopathy although mild cases can manifest with blurred vision early in the 
morning which improves later in the day. Chronic unresolved corneal oedema 
(decompensated corneal oedema) can lead to progressive scarring with severe decline in 
visual acuity. 
Mild stromal oedema secondary to intraoperative trauma usually settles with time. While 
topical steroids can help decrease associated intraocular inflammation and limit further 
insult to the endothelium from inflammation, steroids have no direct effect on the corneal 
endothelium. Reduction of raised IOP can also help the cornea to recover by decreasing 
further damage to the endothelium and while most IOP-lowering drops may be used it is 
better to avoid topical CAIs as they can adversely affect recovery of corneal endothelium. 
Hypertonic saline drops can help improve the symptoms until the cornea recovers but does 
not change the outcome. Bandage contact lenses can also be helpful in decreasing pain from 
ruptured epithelial bullae and recurrent corneal erosions in eyes with advanced corneal 
oedema. Penetrating keratoplasty (PKP) would be the definitive treatment for eyes with 
decompensated corneal oedema to improve the vision. More recently, Descemet’s stripping 
endothelial keratoplasty (DSEK) is becoming more popular and has the advantage of more 
rapid visual recovery and less corneal astigmatism.  
For hard nuclei or in cases with borderline corneal endothelial function, a dispersive 
ophthalmic viscosurgical device (OVD) is of benefit to protect the cornea and decrease the 
severity of postoperative corneal oedema. The best dispersive OVD in our experience is 
Viscoat (40 mg sodium chondroitin sulphate and 30 mg sodium hyaluronate). In this context 
the authors inject the dispersive OVD first and then place the cohesive OVD underneath it 
to form a soft shell as described by Arshinoff (73). Healon5 is a viscoadaptive OVD that 
combines cohesive with dispersive properties and therefore can be used in both routine and 
complex cataract surgery and provides corneal protection  (74). However, caution is needed 
when using Healon5 as overfilling the anterior chamber can result in difficult manipulation 
of the  anterior capsule and can also predispose to phaco burn (74). Creating a fluid space 
around the phaco tip before phacoemulsification should circumvent these problems. This 
can be performed by partially filling the anterior chamber with the OVD and injecting 
balanced salt solution (BSS) underneath, as described by Arshinoff in his ultimate soft-shell 
technique (74, 75). 
7. Conclusion 
Cataract surgery is the commonest surgical operation performed in the world.  
Perioperative complications can be reduced by training and reflective surgical practice. 
Adequate preventive measures, timely diagnosis and early recognition as well as 
appropriate management of complications can decrease ocular morbidity. Posterior capsule 
rupture and vitreous loss is the most common intraoperative complication and is regarded 
as the benchmark of the quality of a surgeons' training and experience. Anticipation of the 
likelihood of complications before, during and after surgery is the most important way to 
reduce complications. 
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